Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Transgene - Filing #858281

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
19 930 EUR
39 593 EUR
Current assets
46 506 EUR
62 245 EUR
Non-current liabilities
15 813 EUR
20 040 EUR
Current liabilities
12 782 EUR
14 589 EUR
Profit (loss)
- EUR
32 804 EUR
- EUR
32 804 EUR
- EUR
32 804 EUR
- EUR
- EUR
- EUR
- EUR
- EUR
19 536 EUR
- EUR
- EUR
19 536 EUR
19 536 EUR
Other comprehensive income
973,000 EUR
372,000 EUR
Comprehensive income
- EUR
32 804 EUR
- EUR
31 831 EUR
- EUR
31 831 EUR
- EUR
973,000 EUR
372,000 EUR
- EUR
- EUR
19 536 EUR
- EUR
- EUR
19 908 EUR
19 908 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.